Skip header and navigation

2 records – page 1 of 1.

Comparison of Streptococcus pneumoniae serotypes causing acute otitis media & invasive disease in young children in the Czech Republic.

https://arctichealth.org/en/permalink/ahliterature30245
Source
Indian J Med Res. 2004 May;119 Suppl:168-70
Publication Type
Article
Date
May-2004
Author
R. Prymula
J. Motlova
P. Kriz
Author Affiliation
Purkyne Military Medical Academy, Hradec Kralove, Prague, Czech Republic.
Source
Indian J Med Res. 2004 May;119 Suppl:168-70
Date
May-2004
Language
English
Publication Type
Article
Keywords
Acute Disease
Comparative Study
Czech Republic - epidemiology
Humans
Infant
Otitis Media - microbiology - prevention & control
Pneumococcal Vaccines - administration & dosage
Prospective Studies
Streptococcal Infections - microbiology - prevention & control
Streptococcus pneumoniae - classification
Abstract
BACKGROUND & OBJECTIVES: The availability of a type-specific pneumococcal vaccine for children is a worldwide problem. It is necessary to study the serotypes prevalent in a country before introducing a type-specific vaccine. The objective of the present study was to analyse the prevalence of Streptococcus pneumoniae serotypes in children suffering from acute otitis media or invasive pneumococcal disease and to compare a coverage of serotypes by individual pneumococcal vaccines. METHODS: Children suffering from acute otitis media and invasive pneumococcal disease were analysed in the Czech Republic from October 1999 to November 2000. Serotyping was performed by the quellung technique using antisera from Statens Serum Institute (Denmark). RESULTS: The most frequent serotypes in patients with acute otitis media were 3, 19F, 23F, 14, 9V, 1, 6B, 11A and 28F. Vaccine coverage for the identified serotypes in acute otitis media patients was 52.1 per cent for the 7-valent vaccine, 57.8 per cent for the 9-valent vaccine and 75.7 per cent for the 11-valent form of the vaccine. In 108 patients with invasive pneumococcal disease, the most frequent serotypes were 6B, 9V, 14, 19F, 3 and 23F. Vaccine coverage for the identified serotypes in patients with invasive pneumococcal disease was 62 per cent for the 7-valent vaccine, 66.4 per cent for the 9-valent vaccine and 77.5 per cent for the 11-valent form of the vaccine. INTERPRETATION & CONCLUSION: Vaccine coverage for the identified serotypes for the 11-valent pneumococcal vaccine was better than the other two vaccines.
PubMed ID
15232187 View in PubMed
Less detail

Online survey: knowledge about risks, prevention and consequences of infections with HBV among travellers from four European countries.

https://arctichealth.org/en/permalink/ahliterature99751
Source
Curr Med Res Opin. 2011 Jan 3;
Publication Type
Article
Date
Jan-3-2011
Author
K H Herbinger
H D Nothdurft
R. Prymula
Author Affiliation
University Hospital, Department of Infectious Diseases and Tropical Medicine, Ludwig-Maximilians University of Munich, Munich, Germany.
Source
Curr Med Res Opin. 2011 Jan 3;
Date
Jan-3-2011
Language
English
Publication Type
Article
Abstract
Abstract Objective: To evaluate knowledge about risks, prevention and consequences of infection with hepatitis B virus (HBV) among travellers from four low HBV risk, European countries. Methods: Individuals from an internet panel and based in the Czech Republic, the Netherlands, Spain and Sweden were invited to take part in an online survey. A total of 4203 respondents met the inclusion criteria and completed the survey. Results: The majority (62.3%) of respondents did not know the main travel destinations with moderate or high prevalence for HBV. Also, 20.1% were somewhat or very unaware of the ways in which HBV can be caught and travellers aged 18-35 years were significantly more likely (p?
PubMed ID
21194400 View in PubMed
Less detail